Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Allison Wey?

Allison H. Wey

Vice President, Investor Relations and Corporate Communications

Regulus Therapeutics Inc.

HQ Phone:  (888) 734-8587

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Regulus Therapeutics Inc.

3545 John Hopkins Court

San Diego, California,92121

United States

Company Description

Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-bala...more

Background Information

Employment History

Vice President

Investor Relations & Corporate Communications


Vice President, Investor Relations and Public Affairs

Durata Therapeutics Inc


Vice President, Investor Relations and Corporate Affairs

Par Pharmaceutical Companies , Inc.


Vice President, Investor Relations

Boron , Lepore & Associates , Inc.


Web References(96 Total References)


Joseph "Jay" Hagan - Regulus Therapeutics

regulusrx.com [cached]

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications


Allison Wey - Regulus Therapeutics

regulusrx.com [cached]

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications Allison Wey In May, 2016, Allison Wey was appointed Vice President, Investor Relations and Corporate Communications for Regulus Therapeutics. Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations, and investment banking. Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey also worked in media relations and corporate communications leadership roles including VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc.


Dan Chevallard - Regulus Therapeutics

regulusrx.com [cached]

Allison Wey
Vice President, Investor Relations and Corporate Communications Allison Wey Vice President, Investor Relations and Corporate Communications


Leadership Updates

www.leadershipdirectories.com [cached]

Regulus Therapeutics, Inc. appointed Allison Wey Vice President of Investor Relations and Corporate Communications.


Press Releases - Regulus Therapeutics Inc.

ir.regulusrx.com [cached]

Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications
LA JOLLA, Calif., May 23, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that Allison Wey has been appointed Vice President, Investor Relations and Corporate Communications. Ms. Wey brings over 25 years of ...


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory